Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. ADR (NQ: SNY )

48.49 -0.32 (-0.66%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,062,950
Open 48.50
Bid (Size) 48.00 (3)
Ask (Size) 49.57 (1)
Prev. Close 48.81
Today's Range 48.33 - 48.80
52wk Range 36.91 - 58.10
Shares Outstanding 1,250,690,553
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 Blue-Chip Stocks to Buy as a New Bull Market Emerges
Many blue-chip stocks look like a bargain right now, and these seven companies are certainly no exception. 
Via InvestorPlace
Hopeful Golden Cross Forms On Sanofi's Chart
 
Via Benzinga

Performance

YTD
-1.04%
-1.04%
1 Month
-0.12%
-0.12%
3 Month
+12.17%
+12.17%
6 Month
-0.84%
-0.84%
1 Year
-8.06%
-8.06%

More News

Read More
Mergers and Acquisitions in 2023 Off To A Strong Start
Via MarketBeat
Exposures Product Safety
Wall Street Thinks These 2 Blazing Healthcare Stocks Could Have 21% to 30% Upside in 2023
Via The Motley Fool
Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market
Via Investor's Business Daily
What Does Sanofi's Debt Look Like?
Via Benzinga
Sanofi Forecasts Foreign Exchange, Record Flu Vaccine Sales To Boost Q4 Earnings
Via Benzinga
The Viral “Tripledemic” Opportunity
Via Talk Markets
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
Via Benzinga
Sanofi Opts To Terminate Rare Disease Program With Regulus Therapeutics
Via Benzinga
What This Drug News Could Mean for Sanofi Shareholders
Via The Motley Fool
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
Via InvestorPlace
FDA Permits Pharmacies To Distribute Abortion Pills, Tesla's Aggressive Discounting May Have Hit Gross Margins, Goldman Sachs Bullish On M&A Activity In Late 2023: Top Stories Today
Via Benzinga
Could This Drug News Give a Lift to Eli Lilly Stock?
Via The Motley Fool
3 Medical Dividend Stocks That Hit the Sweet Spot
Via The Motley Fool
After Five Years Of Collaboration, Sanofi & Innate Pharma Expand Oncology Pact With Additional Programs
Via Benzinga
Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology
From Innate Pharma SA
Via Business Wire
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review
Via Investor's Business Daily
2 Best Biotech Stocks to Buy Right Now
Via The Motley Fool
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis
Via Benzinga
These Biotech Stocks Are the Nasdaq's Big Wednesday Winners
Via The Motley Fool
Why Is Kymera Therapeutics (KYMR) Stock Up 20% Today?
Via InvestorPlace
Kymera Therapeutics Stock Jumps After Positive Data From Atopic Dermatitis Trial
Via Benzinga
Why Small Biotech Kymera Just Snagged Sanofi's Interest And Surged 28%
Via Investor's Business Daily
Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.